Skip to content

Transcranial sonography in Parkinson*s Disease and Restless Legs Syndrome

Transcranial sonography in Parkinson*s Disease and Restless Legs Syndrome - TCS in PD and RLS

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON32740
Enrollment
120
Registered
2008-10-29
Start date
2008-09-01
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

animarum tibiarum Ekbom syndrome restless legs

Interventions

None listed

Sponsors

Medisch Centrum Haaglanden
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria PD patients with RLS 1.Fulfillment of the United Kingdom PD Society Brain Bank criteria for idiopathic PD. 2.Definite RLS in which all four revised minimal criteria of RLS are fulfilled based on an personal history taken by a RLS trained investigator/ doctor;Inclusion criteria PD without RLS 1.Fulfillment of the United Kingdom PD Society Brain Bank criteria for idiopathic PD. 2.Definite no diagnosis of RLS based on a personal history taken by a RLS trained investigator/ doctor 3.Age, sex , PD severity (Hoehn & Yahr and total levodopa-equivalent) matched to the PD patients with RLS;Inclusion criteria of RLS without PD 1.Definite RLS in which all four revised minimal criteria of RLS are fulfilled based on an personal history taken by a RLS trained investigator/ doctor 2.All secondary RLS patients are excluded besides iron deficiency related RLs 3.Age and sex matched to the PD patients;Inclusion criteria healthy controls 1. Definite no RLS or other known diseases 2. Age and sex matched to the RLS patients without PD

Exclusion criteria

Exclusion criteria: 1.No temporal bone window to perform a qualitatively good transcranial sonography 2.Iron medication 3.Pregnancy

Design outcomes

Primary

MeasureTime frame
To determine the echogenicity of the substantia nigra, red nucleus and brain stem raphe in these four groups

Secondary

MeasureTime frame
To determine the serum iron status in these four groups To determine the relation between echogenicity and iron status in the four groups

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)